|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.560 EUR | -1.02% |
|
-2.01% | -2.62% |
| 05-15 | Innate Pharma soars following reassuring quarterly update on clinical pipeline |  |
| 05-13 | Innate Pharma S.A., Q1 2026 Earnings Call, May 13, 2026 |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bullish | Neutral |
| Resistance | 1.71 | 1.96 | 2.01 |
| Spread/Res. | -8.77% | -20.41% | -22.39% |
| Spread/Supp. | +1.69% | +10.64% | +45.25% |
| Support | 1.534 | 1.41 | 1.074 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- IPH Stock
- Charts Innate Pharma
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
